Skip to content
Get alerts
GovInfoNow
Unrated Drug recall · FDA · Published February 23, 2023

Teva Clear Eyes Eye Allergy Relief: Impurities Risk

Teva recalls Clear Eyes allergy eye drops due to impurities found in stability testing. Affected lots expire May 2023 through February 2024. No remedy specified in recall notice.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0469-2023DrugTeva Pharmaceuticals ›
Take action

Contact the company

Recalling firmTeva Pharmaceuticals USA Inc400 Interpace Pkwy Bldg A · Parsippany, NJ 07054-1120
✎ GovInfoNow plain-language explainer

Teva Pharmaceuticals is recalling Clear Eyes eye allergy relief drops because stability testing found impurities. This could pose a risk to eye health if the product is used. Read more at govinfonow.com/recall/33855-teva-clear-eyes-eye-allergy-relief-impurities-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/33855-teva-clear-eyes-eye-allergy-relief-impurities-risk · Updated August 18, 2026 · FDA enforcement record: FDA #D-0469-2023

Cite this page

“Teva Clear Eyes Eye Allergy Relief: Impurities Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/33855-teva-clear-eyes-eye-allergy-relief-impurities-risk. Based on FDA recall #D-0469-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0469-2023%22&limit=1).

The FDA announced on Feb. 23, 2023, that Teva Pharmaceuticals USA Inc voluntarily recalled Clear Eyes Once Daily Eye Allergy Itch Relief due to failed impurity specifications. The recall affects 715,632 bottles distributed nationwide.

How to tell if you have it

  • Brand: Teva Pharmaceuticals
  • Product: Clear Eyes, Once Daily, Eye Allergy Itch Relief, olopatadine hydrochloride ophthalmic solution, USP, 0.2%
  • UPC: 678112000708
  • Lot #114349, Exp. 05/2023
  • Lot 117396, Exp. 09/2023
  • Lot 120128, Exp. 11/2023
  • Lot 114371, Exp. 06/2023
  • Lot 123781, Exp. 02/2024

The hazard

According to the FDA, an out-of-specification stability test result was obtained for an unspecified impurity in the product.

Context

GovInfoNow's records show Teva Pharmaceuticals USA, Inc has 59 other recalls on record since 2012-04-02. Other recent recalls of similar products include a TraZODone recall (2026-08-24) and an Octreotide Acetate Kit recall (2026-04-24). Clear Eyes Eye Drops were recalled for sterility risk on 2026-09-15 and 2026-07-29, while TRP Gentle Eyes Lubricant Eye Drops faced a lack of sterility assurance recall on 2026-08-20.

How to tell if you have this one

Check the bottle label for the product name 'Clear Eyes, Once Daily, Eye Allergy Itch Relief' and the lot numbers listed: 114349 (exp. 05/2023), 117396 (exp. 09/2023), 120128 (exp. 11/2023), 114371 (exp. 06/2023), or 123781 (exp. 02/2024).

  • Brand
    Teva Pharmaceuticals
  • Product
    Teva Pharmaceuticals USA Inc recalls Clear Eyes, Once Daily, Eye Allergy Itch Relief, olopatadine hydrochloride ophthalmic solution, USP, 0.2%
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Label

    Look for the lot numbers 114349, 117396, 120128, 114371, or 123781 on the bottle.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the U.S.A.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 9 months after the firm started it.

1. Firm started the recall: Feb 23, 202312. FDA classified it Class II: Mar 20, 202323. Published in FDA’s Enforcement Report: Mar 22, 202334. FDA terminated the recall: Nov 28, 202342023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Clear Eyes Eye Drops Recall: Lack of Sterility Risk
Insight PharmaceuticalsAmerican Health Packaging Recalls Metoclopramide Tablets Due to Foreign Drug Presence
American Health PackagingTeva Recalls Metoclopramide Tablets Due to Foreign Contaminants
Teva Pharmaceuticals USA, IncPreferred Pharma Recalls Lidocaine Ointment Due to Content Issues
Preferred Pharmaceuticals, Inc.Northstar Rx Recalls Tretinoin Cream Due to Impurities
SUN PHARMACEUTICAL INDUSTRIES INC

Other Teva Pharmaceuticals recalls

Teva Pharmaceuticals USA, Inc recalls traZODone Hydrochloride Tablets, USP, 50 mg, Rx only, 100 Tablets, Manufactured in Croatia By: Pliva Hrvatska d.o.o,
August 24, 2026Teva Pharmaceuticals USA, Inc recalls Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 30 mg, In Single-Dose kits containing:
April 24, 2026Teva Pharmaceuticals USA, Inc recalls Claravis (isotretinoin capsule, USP), 10 mg, Packaged as a) 100-count carton, NDC 0555-1054-56, with 10x10 blister
April 6, 2026Teva Pharmaceuticals USA, Inc recalls Clonidine Transdermal System, USP, 0.2 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only,
March 19, 2026Teva Pharmaceuticals USA, Inc recalls Metoprolol Succinate Extended-Release Tablets, 50 mg, 100 tablets bottles (NDC: 45963-676-11) and 1,000 tablets bottles
January 29, 2026Teva Pharmaceuticals USA, Inc recalls Isotretinoin Capsules, USP, 40 mg, 10 count Prescription Pacs, Rx only, Manufactured for: Teva Pharmaceuticals USA,
January 12, 2026

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0469-2023 (February 23, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0469-2023 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA